Inhibition of human leukocyte elastase by derivatives of N-hydroxysuccinimide. A structure-activity-relationship study

No Thumbnail Available
Authors
Groutas, William C.
Brubaker, Michael J.
Stanga, Michael A.
Castrisos, J.C.
Crowley, J.P.
Schatz, E. J.
Advisors
Issue Date
1989-07-01
Type
Article
Keywords
Research Support, U.S. Gov't, P.H.S.
Research Projects
Organizational Units
Journal Issue
Citation
Journal of medicinal chemistry. 1989 Jul; 32(7): 1607-11.
Abstract

A series of compounds derived from 3-alkyl-N-hydroxysuccinimide have been synthesized and their inhibitory activity toward human leukocyte elastase has been investigated. Compounds having an isobutyl or isopropyl group at the C-3 position have been found to be particularly effective inactivators of the enzyme. The introduction of a trans-styryl group (as in compounds 16 and 18) results in a drastic enhancement in inhibitory activity indicative of a favorable interaction between the phenyl ring and the S2' subsite of the enzyme. The compounds were found to be highly stable in buffer solution with no apparent change in structural integrity after 17 h (the period of observation). Studies with model compounds and high-field NMR indicate that these compounds function as mechanism-based inhibitors of the enzyme. Porcine pancreatic elastase is not inhibited by these compounds, while chymotrypsin and human leukocyte cathepsin G are also efficiently inactivated.

Table of Contents
Description
Full text of this article is not available in SOAR.
Publisher
American Chemical Society
Journal
Book Title
Series
Journal of medicinal chemistry
J. Med. Chem.
PubMed ID
DOI
ISSN
0022-2623
EISSN